87899064 - NTX

Information

  • Trademark
  • 87899064
  • Serial Number
    87899064
  • Registration Number
    5968170
  • Filing Date
    April 28, 2018
    6 years ago
  • Registration Date
    January 21, 2020
    4 years ago
  • Transaction Date
    October 24, 2024
    a month ago
  • Status Date
    January 21, 2020
    4 years ago
  • Published for Opposition Date
    April 09, 2019
    5 years ago
  • Location Date
    December 16, 2019
    5 years ago
  • First Use Anywhere Date
    August 16, 2018
    6 years ago
  • First Use In Commerce Date
    August 16, 2018
    6 years ago
  • Status Code
    700
  • Current Location
    PUBLICATION AND ISSUE SECTION
    Employee Name
    DONEGAN, DANIEL
  • Attorney Docket Number
    90125.00040
    Attorney Name
    David Kerr
    Law Office Assigned Location Code
    L40
  • Owners
Mark Drawing Code
4
Mark Identification
NTX
Case File Statements
  • GS0401: Custom manufacturer of pharmaceutical and biopharmaceutical compounds, namely, antibiotics, proteins, vaccines, enzymes, and small molecules
  • GS0421: Research and development of pharmaceuticals, therapeutics, and biologics, namely, vaccines, antibiotics, vaccines generated in a cell-free protein synthesizing system, antibiotics generated in a cell-free protein synthesizing system, proteins generated in a cell-free protein synthesizing system, and enzymes generated in a cell-free protein synthesizing system; research and development in the field of bioinformatics and production of proteins in cell-free systems for the development of vaccines, and antibiotics; medical research and development in the field of synthetic biology, molecular biology, genetic engineering and bioinformatics; research and development of new drug compounds for therapeutic use; research and development of new biological products for therapeutic use; research and development of antibiotic compounds for therapeutic use; research and development of methods of high-throughput screening of biological materials; research and development of methods of rapid-prototyping of biological materials; research and development of methods of real-time metabolic profiling of bacteria, fungi and plants to discover, characterize and produce bioactive products; design and development of nucleic acids, proteins, enzymes, antibiotic compounds, and drug compounds for use in pharmaceuticals, biotechnology, and medical and diagnostic applications using predictive bioinformatics; bioinformatics scientific research services, namely, identifying new drug compounds from analysis of genomic data
Case File Event Statements
  • 5/2/2018 - 6 years ago
    1 - NEW APPLICATION ENTERED Type: NWAP
  • 5/8/2018 - 6 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 8/20/2018 - 6 years ago
    3 - ASSIGNED TO EXAMINER Type: DOCK
  • 8/21/2018 - 6 years ago
    4 - PRIORITY ACTION WRITTEN Type: CPRA
  • 8/21/2018 - 6 years ago
    5 - PRIORITY ACTION E-MAILED Type: GPRA
  • 8/21/2018 - 6 years ago
    6 - NOTIFICATION OF PRIORITY ACTION E-MAILED Type: GPRN
  • 2/18/2019 - 5 years ago
    7 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 2/25/2019 - 5 years ago
    8 - ASSIGNED TO LIE Type: ALIE
  • 2/25/2019 - 5 years ago
    9 - ASSIGNED TO LIE Type: ALIE
  • 2/26/2019 - 5 years ago
    10 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 2/26/2019 - 5 years ago
    11 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 2/27/2019 - 5 years ago
    12 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 3/20/2019 - 5 years ago
    13 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 4/9/2019 - 5 years ago
    14 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 4/9/2019 - 5 years ago
    15 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 6/4/2019 - 5 years ago
    16 - NOA E-MAILED - SOU REQUIRED FROM APPLICANT Type: NOAM
  • 12/3/2019 - 5 years ago
    17 - TEAS STATEMENT OF USE RECEIVED Type: EISU
  • 12/3/2019 - 5 years ago
    19 - USE AMENDMENT FILED Type: IUAF
  • 12/10/2019 - 5 years ago
    18 - CASE ASSIGNED TO INTENT TO USE PARALEGAL Type: AITU
  • 12/10/2019 - 5 years ago
    20 - STATEMENT OF USE PROCESSING COMPLETE Type: SUPC
  • 12/16/2019 - 5 years ago
    21 - ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED Type: CNPR
  • 12/17/2019 - 5 years ago
    22 - NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED Type: SUNA
  • 1/21/2020 - 4 years ago
    23 - REGISTERED-PRINCIPAL REGISTER Type: R.PR
  • 12/9/2020 - 4 years ago
    24 - AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP Type: ASGN
  • 10/23/2024 - a month ago
    25 - ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY Type: ASCK